Skip to content

Insider · CIK 0001365619

Laura Brege

director

Files at ACAD (ACADIA PHARMACEUTICALS INC), PCRX (Pacira BioSciences, Inc.), EWTX (Edgewise Therapeutics, Inc.), MIRM (Mirum Pharmaceuticals, Inc.). First filing Jun 5, 2025, latest Sep 12, 2025.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 2
$0 bought, $1.6M sold

Where the trades landed

Last year at the 2 companies this insider has traded most, with each buy and sell on the bar it happened.

MIRM: Mirum Pharmaceuticals, Inc.

MIRMOct 9, 2026 · close 86.01

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

ACAD: ACADIA PHARMACEUTICALS INC

ACADOct 9, 2026 · close 19.78

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

This insider’s open-market buys and sells, scored.

ScoreCompanyValueHoldingsPrice contextFiled
53Moderate
MIRMsell 2
Mirum Pharmaceuticals, Inc.
$1.3M
17,000 shares
-52%+101% from low-2% from high
39Weak
ACADsell
ACADIA PHARMACEUTICALS INC
$315k
14,446 shares
-49%+54% from low-2% from high

Transactions

Every row this insider has filed, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Sep 11, 2025MIRM
Mirum Pharmaceuticals, Inc.
MOption exercise
Common Stock
+17,000$15.00$255k32,703Sep 12, 2025
Sep 11, 2025MIRM
Mirum Pharmaceuticals, Inc.
SOpen-market sale
Common Stock
-15,509$74.34$1.2M17,194Sep 12, 2025
Sep 11, 2025MIRM
Mirum Pharmaceuticals, Inc.
SOpen-market sale
Common Stock
-1,491$75.07$112k15,703Sep 12, 2025
Sep 11, 2025MIRM
Mirum Pharmaceuticals, Inc.
MOption exercise
Stock Option (right to buy)derivative
-17,000$0.00$00Sep 12, 2025
Jun 16, 2025EWTX
Edgewise Therapeutics, Inc.
AGrant or award
Stock Option (Right to Buy)derivative
+30,000$0.00$030,000Jun 18, 2025
Jun 11, 2025PCRX
Pacira BioSciences, Inc.
AGrant or award
Common Stock
+6,163$0.00$023,715Jun 13, 2025
Jun 11, 2025PCRX
Pacira BioSciences, Inc.
AGrant or award
Stock Option (Right to Buy)derivative
+11,279$0.00$011,279Jun 13, 2025
Jun 4, 2025ACAD
ACADIA PHARMACEUTICALS INC
SOpen-market sale
Common Stock
-14,446$21.78$315k15,095Jun 5, 2025
May 29, 2025ACAD
ACADIA PHARMACEUTICALS INC
MOption exercise
Common Stock
+9,387--29,541Jun 2, 2025
May 29, 2025MIRM
Mirum Pharmaceuticals, Inc.
MOption exercise
Common Stock
+5,703--15,703Jun 2, 2025
May 29, 2025ACAD
ACADIA PHARMACEUTICALS INC
MOption exercise
Restricted Stock Unitsderivative
-9,387$0.00$00Jun 2, 2025
May 29, 2025MIRM
Mirum Pharmaceuticals, Inc.
MOption exercise
Restricted Stock Unitsderivative
-5,703$0.00$00Jun 2, 2025
May 29, 2025ACAD
ACADIA PHARMACEUTICALS INC
AGrant or award
Director Stock Options (Right to Buy)derivative
+13,793$0.00$013,793Jun 2, 2025
May 29, 2025MIRM
Mirum Pharmaceuticals, Inc.
AGrant or award
Stock Option (right to buy)derivative
+6,268$0.00$06,268Jun 2, 2025
May 29, 2025ACAD
ACADIA PHARMACEUTICALS INC
AGrant or award
Restricted Stock Unitsderivative
+8,107$0.00$08,107Jun 2, 2025
May 29, 2025MIRM
Mirum Pharmaceuticals, Inc.
AGrant or award
Deferred Stock Unitsderivative
+3,977$0.00$03,977Jun 2, 2025

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Laura Brege: insider trades and track record | InsiderTell